Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.05.2023 | Case report

Ipilimumab/pembrolizumab

Ileus: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Gao S, et al. Ileus in patients treated with immune checkpoint inhibitors: A retrospective, pharmacovigilance study using Food and Drug Administration Adverse Event Reporting System database. Pharmacoepidemiology and Drug Safety 31 : 1199-1205, No. 11, Nov 2022. Available from: URL: http://doi.org/10.1002/pds.5493 Gao S, et al. Ileus in patients treated with immune checkpoint inhibitors: A retrospective, pharmacovigilance study using Food and Drug Administration Adverse Event Reporting System database. Pharmacoepidemiology and Drug Safety 31 : 1199-1205, No. 11, Nov 2022. Available from: URL: http://​doi.​org/​10.​1002/​pds.​5493
Metadaten
Titel
Ipilimumab/pembrolizumab
Ileus: case report
Publikationsdatum
01.05.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-38900-x

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Clofarabine

Case report

Aumolertinib